Is IFC.PRE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of IFC.PRE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IFC.PRE (CA$21.86) is trading below our estimate of fair value (CA$33.48)
Significantly Below Fair Value: IFC.PRE is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IFC.PRE?
Key metric: As IFC.PRE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for IFC.PRE. This is calculated by dividing IFC.PRE's market cap by their current
earnings.
What is IFC.PRE's PE Ratio?
PE Ratio
23.6x
Earnings
CA$2.06b
Market Cap
CA$48.55b
IFC.PRE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: IFC.PRE is expensive based on its Price-To-Earnings Ratio (23.6x) compared to the North American Insurance industry average (13.1x).
Price to Earnings Ratio vs Fair Ratio
What is IFC.PRE's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
IFC.PRE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
23.6x
Fair PE Ratio
13.9x
Price-To-Earnings vs Fair Ratio: IFC.PRE is expensive based on its Price-To-Earnings Ratio (23.6x) compared to the estimated Fair Price-To-Earnings Ratio (13.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.